Start Up
B2B 24-7 Mobile Drug Testing Franchise! Low Investment and HIgh ROI!
AI-Resistant B2B Start Up Franchise | National Accounts | No Labor!

$28,000,000
EBITDA: View Profit
Structural DTC Shifts Amplifying EBITDA to $5.045 Million
Includes Real Estate
Financing Available
$28,000,000
EBITDA: View Profit

$6,000,000
View Profit
$6,000,000
View Profit
$1,350,000
$1,350,000


